Neurocognitive effects of HIV, hepatitis C, and substance use history

Journal of the International Neuropsychological Society

Volumn 18, Issue 1, 2012, Pages 68-78

  Devlin, Kathryn N ^a   Gongvatana, Assawin ^a,b   Clark, Uraina S ^a,b   Chasman, Jesse D ^a,b   Westbrook, Michelle L ^a   Tashima, Karen T ^a,b   Navia, Bradford ^c   Cohen, Ronald A ^a,b  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic hepatitis C; Cocaine dependence; HIV 1; Neuropsychology; Opiate dependence; Viral load

Indexed keywords

EID: 84855184670     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617711001408     Document Type: Article

References (116)

1. Ances, B.M., Vaida, F., Yeh, M.J., Liang, C.L., Buxton, R.B., Letendre, S., y Ellis, R.J. (2010). HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. Journal of Infectious Diseases, 201(3), 336-340.
2. Armstrong, G.L., Wasley, A., Simard, E.P., McQuillan, G.M., Kuhnert, W.L., & Alter, M.J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705-714. (Pubitemid 46780630)
3. Bajaj, J.S., Wade, J.B., & Sanyal, A.J. (2009). Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology, 50(6), 2014-2021.
4. Basso, M.R., & Bornstein, R.A. (2000). Neurobehavioural consequences of substance abuse and HIV infection. Journal of Psychopharmacology, 14(3), 228-237.
5. Benedict, R.H.B. (1997). Brief Visuospatial Memory Test - Revised. Odessa, FL: Psychological Assessment Resources.
6. Benedict, R.H.B., Schretlen, A., Groninger, L., & Brandt, J. (1998). Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 43-55. (Pubitemid 28168220)
7. Benedict, R.H.B., Schretlen, D., Groninger, L., Dobraski, M., & Shpritz, B. (1996). Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychological Assessment, 8(2), 145-153. (Pubitemid 26236038)
8. Benton, A.L., Hamsher, K., & Sivan, A.B. (1994). Multilingual Aphasia Examination. Iowa City: AJA Associates.
9. Bica, I.,McGovern, B., Dhar, R., Stone,D.,McGowan, K., Scheib, R., & Snydman, D.R. (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 32(3), 492-497. (Pubitemid 32173638)
10. Bornstein, R.A., Nasrallah, H.A., Para, M.F., Whitacre, C.C., & Fass, R.J. (1994). Duration of illness and neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 6(2), 160-164. (Pubitemid 24143945)
11. Brandt, J., & Benedict, R.H.B. (1991). Hopkins Verbal Learning Test-Revised (HVLT-R). Lutz, FL: Psychological Assessment Resources, Inc.
12. Brew, B.J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(Suppl. 1), S75-S78. (Pubitemid 38365909)
13. Brew, B.J., Crowe, S.M., Landay, A., Cysique, L.A., & Guillemin, G. (2009). Neurodegeneration and ageing in the HAART era. Journal of Neuroimmune Pharmacology, 4(2), 163-174.
14. Brown, T.T., Cole, S.R., Li, X., Kingsley, L.A., Palella, F.J., Riddler, S.A., y Dobs, A.S. (2005). Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine, 165(10), 1179-1184. (Pubitemid 40720744)
15. Carey, C.L., Woods, S.P., Gonzalez, R., Conover, E., Marcotte, T.D., Grant, I., & Heaton, R.K. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307-319. (Pubitemid 39277061)
16. Carrat, F., Bani-Sadr, F., Pol, S., Rosenthal, E., Lunel-Fabiani, F., Benzekri, A., y Perronne, C. (2004). Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. JAMA, 292(23), 2839-2848. (Pubitemid 39628231)
17. Chang, L., Ernst, T., Witt, M.D., Ames, N., Gaiefsky, M., & Miller, E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage, 17(3), 1638-1648. (Pubitemid 35333882)
18. Chen, Y.,An, H., Zhu,H., Stone, T., Smith, J.K., Hall, C.,yLin,W. (2009). White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV1 patients. Neuroimage, 47(4), 1154-1162.
19. Cherner, M., Ellis, R.J., Lazzaretto, D., Young, C., Mindt, M.R., Atkinson, J.H., y Heaton, R.K. (2004). Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS, 18(Suppl. 1), S27-S34. (Pubitemid 38365903)
20. Cherner, M., Letendre, S., Heaton, R.K., Durelle, J., Marquie-Beck, J., Gragg, B., & Grant, I. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 1343-1347. (Pubitemid 40570498)
21. Childs, E.A., Lyles, R.H., Selnes, O.A., Chen, B., Miller, E.N., Cohen, B.A., y McArthur, J.C. (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52(3), 607-613. (Pubitemid 29075612)
22. Chung, R.T., Andersen, J., Volberding, P., Robbins, G.K., Liu, T., Sherman, K.E.,yvan der Horst, C. (2004). Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine, 351(5), 451-459. (Pubitemid 38988594)
23. Clifford, D.B. (2008). HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV Medicine, 16(2), 94-98.
24. Clifford, D.B., Evans, S.R., Yang, Y., & Gulick, R.M. (2005). The neuropsychological and neurological impact of hepatitis C virus coinfection in HIV-infected subjects. AIDS, 19(Suppl. 3), S64-S71. (Pubitemid 41682171)
25. Clifford, D.B., Smurzynski, M., Park, L.S., Yeh, T.M., Zhao, Y., Blair, L., y Evans, S.R. (2009). Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology, 73(4), 309-314.
26. Cohen, R.A., Boland, R., Paul, R., Tashima, K.T., Schoenbaum, E.E., Celentano, D.D., y Carpenter, C.C. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15(3), 341-345. (Pubitemid 32163820)
27. Cohen, R.A., de la Monte, S., Gongvatana, A., Ombao, H., Gonzalez, B., Devlin, K.N., y Tashima, K.T. (2011). Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. Journal of Neuroimmunology, 233(1-2), 204-210.
28. Cohen, R.A., Harezlak, J., Gongvatana, A., Buchthal, S., Schifitto, G., Clark, U.,yNavia, B. (2010). Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of Neurovirology, 16(6), 435-444.
29. Cohen, R.A., Harezlak, J., Schifitto, G., Hana, G., Clark, U., Gongvatana, A.,yNavia, B. (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology, 16(1), 25-32.
30. Compton, W.M., Thomas, Y.F., Stinson, F.S., & Grant, B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576. (Pubitemid 46718289)
31. Crum, N.F., Riffenburgh, R.H.,Wegner, S., Agan, B.K., Tasker, S.A., Spooner, K.M.,yWallace, M.R. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41(2), 194-200.
32. Cysique, L.A., Maruff, P., & Brew, B.J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 1447-1450. (Pubitemid 43739663)
33. Cysique, L.A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S.P.,yEllis, R.J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342-348.
34. Davis, P.E., Liddiard, H., & McMillan, T.M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67(1), 105-108. (Pubitemid 34615933)
35. de la Monte, S.M., Longato, L., Tong,M., DeNucci, S., &Wands, J.R. (2009). The liver-brain axis of alcohol-mediated neurodegeneration: Role of toxic lipids. International Journal of Environmental Research and Public Health, 6(7), 2055-2075.
36. de la Monte, S.M., Tong,M., Nguyen, V., Setshedi,M., Longato, L., & Wands, J.R. (2010). Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. Journal of Alzheimer's Disease, 21(3), 967-984.
37. Deeks, S.G., & Phillips, A.N. (2009). HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ (Clinical Research Ed.), 338, a3172.
38. Di Sclafani, V., Tolou-Shams, M., Price, L.J., & Fein, G. (2002). Neuropsychological performance of individuals dependent on crackcocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug and Alcohol Dependence, 66(2), 161-171. (Pubitemid 34242893)
39. Eldreth, D.A., Matochik, J.A., Cadet, J.L., & Bolla, K.I. (2004). Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage, 23(3), 914-920. (Pubitemid 39446525)
40. Ellis, R., Langford, D., & Masliah, E. (2007). HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nature Reviews. Neuroscience, 8(1), 33-44. (Pubitemid 46011997)
41. Ersche, K.D., Clark, L., London, M., Robbins, T.W., & Sahakian, B.J. (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31(5), 1036-1047.
42. Fals-Stewart, W., Schafer, J., Lucente, S., Rustine, T., & Brown, L. (1994). Neurobehavioral consequences of prolonged alcohol and substance abuse: A review of findings and treatment implications. Clinical Psychology Review, 14(8), 755-778.
43. Fein, G., Torres, J., Price, L.J., & Di Sclafani, V. (2006). Cognitive performance in long-term abstinent alcoholic individuals. Alcoholism, Clinical and Experimental Research, 30(9), 1538-1544. (Pubitemid 44272743)
44. Fernandez-Serrano, M.J., Perez-Garcia, M., Schmidt Rio-Valle, J., & Verdejo-Garcia, A. (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of Psychopharmacology, 24(9), 1317-1332.
45. Fernandez-Serrano, M.J., Perez-Garcia, M., & Verdejo-Garcia, A. (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35(3), 377-406.
46. Forton, D.M., Allsop, J.M., Cox, I.J., Hamilton, G., Wesnes, K., Thomas, H.C., & Taylor-Robinson, S.D. (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, 19(Suppl. 3), S53-S63. (Pubitemid 41682170)
47. Forton, D.M., Allsop, J.M., Main, J., Foster, G.R., Thomas, H.C., & Taylor-Robinson, S.D. (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet, 358(9275), 38-39. (Pubitemid 32709741)
48. Forton, D.M., Thomas,H.C., Murphy, C.A., Allsop, J.M., Foster, G.R., Main, J., y Taylor-Robinson, S.D. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35(2), 433-439. (Pubitemid 34106386)
49. Golden, C.J. (1978). Stroop Color and Word Test. Chicago: Stoelting.
50. Gongvatana, A., Cohen, R.A., Correia, S., Devlin, K.N., Miles, J., Clark, U.S., y Tashima, K.T. (2011, February). Impact of Hepatitis C and HIV coinfection on cerebral white matter integrity. Proceedings of the 39th Annual Meeting of the International Neuropsychological Society, Boston, MA.
51. Gongvatana, A., Schweinsburg, B.C., Taylor, M.J., Theilmann, R.J., Letendre, S.L., Alhassoon, O.M.,yGrant, I. (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. Journal of Neurovirology, 15(2), 187-195.
52. Grant, B.F. (1996). Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse, 8(2), 195-210. (Pubitemid 26312779)
53. Green, J.E., Saveanu, R.V., & Bornstein, R.A. (2004). The effect of previous alcohol abuse on cognitive function in HIV infection. American Journal of Psychiatry, 161(2), 249-254. (Pubitemid 38419275)
54. Gruber, S.A., Silveri, M.M., & Yurgelun-Todd, D.A. (2007). Neuropsychological consequences of opiate use. Neuropsychology Review, 17(3), 299-315. (Pubitemid 47498184)
55. Harezlak, J., Buchthal, S., Taylor,M., Schifitto, G., Zhong, J., Daar, E., y Navia, B. (2011). Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS, 25(5), 625-633.
56. Hasin, D.S., Stinson, F.S., Ogburn, E., & Grant, B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830-842. (Pubitemid 47026379)
57. Heaton, R.K., Clifford, D.B., Franklin, D.R., Jr., Woods, S.P., Ake, C., Vaida, F., y Grant, I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087-2096.
58. Heaton, R.K., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, J.H.,ythe HNRC Group. (1995). The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 1(3), 231-251.
59. Heaton, R.K., Miller, W., Taylor, M., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
60. Hesselink, J.R., Tien, R., Spoto, G., Jernigan, T.L., & Grant, I. (1991, June). Accelerated brain atrophy and parenchymal change in patients with AIDS. Proceedings of the International Conference on AIDS, Florence, Italy.
61. Hilsabeck, R.C., Castellon, S.A., & Hinkin, C.H. (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41(Suppl. 1), S38-S44. (Pubitemid 40863723)
62. Hilsabeck, R.C., Perry, W., & Hassanein, T.I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35(2), 440-446. (Pubitemid 34106387)
63. Hinkin, C.H., Castellon, S.A., Levine, A.J., Barclay, T.R., & Singer, E.J. (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. Journal of Addictive Diseases, 27(2), 11-17.
64. Janssen, R.S., Saykin, A.J., Cannon, L., Campbell, J., Pinsky, P.F., Hessol, N.A., y Kaplan, J.E. (1989). Neurological and neuropsychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection. Annals of Neurology, 26(5), 592-600.
65. Jernigan, T.L., Archibald, S.,Hesselink, J.R.,Atkinson, J.H.,Velin, R.A., McCutchan, J.A., y Grant, I. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Archives of Neurology, 50(3), 250-255. (Pubitemid 23069608)
66. Kellogg, S.H., McHugh, P.F., Bell, K., Schluger, J.H., Schluger, R.P., LaForge, K.S., y Kreek, M.J. (2003). The Kreek-McHugh- Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence, 69(2), 137-150. (Pubitemid 36259776)
67. Kim, W.R. (2002). The burden of hepatitis C in the United States. Hepatology, 36(5 Suppl. 1), S30-S34. (Pubitemid 35253461)
68. Kløve, H. (1963). Grooved pegboard. Lafayette, IN: Lafayette Instruments.
69. Kramer, L., Bauer, E., Funk, G., Hofer, H., Jessner, W., Steindl- Munda, P.,yFerenci, P. (2002). Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology, 37(3), 349-354. (Pubitemid 34969951)
70. Laskus, T., Radkowski, M., Bednarska, A., Wilkinson, J., Adair, D., Nowicki, M., y Rakela, J. (2002). Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. Journal of Virology, 76(19), 10064-10068. (Pubitemid 35006549)
71. Letendre, S.L., McCutchan, J.A., Childers, M.E., Woods, S.P., Lazzaretto, D., Heaton, R.K., y Ellis, R.J. (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology, 56(3), 416-423. (Pubitemid 39166561)
72. Letendre, S.L., Paulino, A.D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., y Masliah, E. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196(3), 361-370. (Pubitemid 47093886)
73. Lundqvist, T. (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology, Biochemistry and Behavior, 81(2), 319-330. (Pubitemid 40807130)
74. Martin-Thormeyer, E.M., & Paul, R.H. (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: Neurocognitive and neuroimaging features. Neuropsychology Review, 19(2), 215-231.
75. McArthur, J.C. (2004). HIV dementia: An evolving disease. Journal of Neuroimmunology, 157(1-2), 3-10. (Pubitemid 39576633)
76. McArthur, J.C., McClernon, D.R., Cronin, M.F., Nance-Sproson, T.E., Saah, A.J., St Clair, M., & Lanier, E.R. (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology, 42(5), 689-698. (Pubitemid 27481540)
77. McCrea, M., Cordoba, J., Vessey, G., Blei, A.T., & Randolph, C. (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology, 53(8), 758-763. (Pubitemid 26266921)
78. McCutchan, J.A., Wu, J.W., Robertson, K., Koletar, S.L., Ellis, R.J., Cohn, S.,yWilliams, P.L. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 1109-1117. (Pubitemid 46763281)
79. Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A., y Lundgren, J.D. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377), 22-29. (Pubitemid 36835816)
80. Monga, H.K., Rodriguez-Barradas, M.C., Breaux, K., Khattak, K., Troisi, C.L., Velez, M., & Yoffe, B. (2001). Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 33(2), 240-247. (Pubitemid 32643340)
81. Moore, D.J., Masliah, E., Rippeth, J.D., Gonzalez, R., Carey, C.L., Cherner, M., y Grant, I. (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS, 20(6), 879-887. (Pubitemid 43731570)
82. Morgello, S., Estanislao, L., Ryan, E., Gerits, P., Simpson, D., Verma, S., y Sharp, V. (2005). Effects of hepatic function and hepatitis C virus on the nervous system assessment of advancedstage HIV-infected individuals. AIDS, 19(Suppl. 3), S116-S122. (Pubitemid 41682178)
83. Nath, A., Maragos, W.F., Avison, M.J., Schmitt, F.A., & Berger, J.R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology, 7(1), 66-71. (Pubitemid 32904361)
84. O'Malley, S., Adamse, M., Heaton, R.K., & Gawin, F.H. (1992). Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse, 18(2), 131-144.
85. Obel,N., Thomsen, H.F.,Kronborg, G., Larsen, C.S., Hildebrandt, P.R., Sorensen, H.T., & Gerstoft, J. (2007). Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A populationbased cohort study. Clinical Infectious Diseases, 44(12), 1625-1631. (Pubitemid 46871511)
86. Palella,F.J., Jr., Baker, R.K.,Moorman,A.C., Chmiel, J.S.,Wood,K.C., Brooks, J.T., & Holmberg, S.D. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43(1), 27-34. (Pubitemid 44306484)
87. Pascual-Leone, A., Dhuna, A., & Anderson, D.C. (1991). Longterm neurological complications of chronic, habitual cocaine abuse. Neurotoxicology, 12(3), 393-400.
88. Paul, R.H., Ernst, T., Brickman, A.M., Yiannoutsos, C.T., Tate, D.F., Cohen, R.A., & Navia, B.A. (2008). Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. Journal of the International Neuropsychological Society, 14(5), 725-733.
89. Paul, R.H., Yiannoutsos, C.T., Miller, E.N., Chang, L., Marra, C.M., Schifitto, G., y Navia, B.A. (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: Evidence of subcortical specificity. Journal of Neuropsychiatry and Clinical Neurosciences, 19(3), 283-292. (Pubitemid 47293901)
90. Perry, W., Hilsabeck, R.C., & Hassanein, T.I. (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases and Sciences, 53(2), 307-321. (Pubitemid 351170036)
91. Pezawas, L.M., Fischer, G., Diamant, K., Schneider, C., Schindler, S.D., Thurnher, M., y Kasper, S. (1998). Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements. Psychiatry Research, 83(3), 139-147. (Pubitemid 28522505)
92. Phillips, A.N., Neaton, J., & Lundgren, J.D. (2008). The role of HIV in serious diseases other than AIDS. AIDS, 22(18), 2409-2418.
93. Pomara, N., Crandall, D.T., Choi, S.J., Johnson, G., & Lim, K.O. (2001). White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study. Psychiatry Research, 106(1), 15-24. (Pubitemid 32174865)
94. Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., y Bower, M. (2009). Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. Journal of Clinical Oncology, 27(6), 884-890.
95. Radloff, L.S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401.
96. Reitan, R.M. (1992). Trail Making Test. Tucson, AZ: Reitan Neuropsychology Laboratory.
97. Rippeth, J.D., Heaton, R.K., Carey, C.L., Marcotte, T.D., Moore, D.J., Gonzalez, R., y Grant, I. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1-14. (Pubitemid 38128457)
98. Robertson, K.R., Robertson, W.T., Ford, S., Watson, D., Fiscus, S., Harp, A.G., & Hall, C.D. (2004). Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndromes, 36(1), 562-566. (Pubitemid 38544504)
99. Robertson, K.R., Smurzynski, M., Parsons, T.D., Wu, K., Bosch, R.J., Wu, J.,yEllis, R.J. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 1915-1921. (Pubitemid 47329768)
100. Ryan, E.L., Morgello, S., Isaacs, K., Naseer, M.,&Gerits, P. (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62(6), 957-962. (Pubitemid 38435785)
101. Sacktor, N., McDermott, M.P., Marder, K., Schifitto, G., Selnes, O.A., McArthur, J.C., y Epstein, L. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8(2), 136-142. (Pubitemid 34520894)
102. Sherman, K.E., Rouster, S.D., Chung, R.T., & Rajicic, N. (2002). Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 34(6), 831-837. (Pubitemid 34194855)
103. Stern, R.A., Arruda, J.E., Somerville, J.A., Cohen, R.A., Boland, R.J., Stein, M.D., & Martin, E.M. (1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4(2), 172-178. (Pubitemid 28156092)
104. Stoff, D.M. (2004). Mental health research in HIV/AIDS and aging: Problems and prospects. AIDS, 18(Suppl. 1), S3-S10. (Pubitemid 38365900)
105. Tarter, R.E., Hegedus, A.M., Van Thiel, D.H., Schade, R.R., Gavaler, J.S., & Starzl, T.E. (1984). Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology, 86(6), 1421-1427. (Pubitemid 14147933)
106. Thompson, P.M., Dutton, R.A., Hayashi, K.M., Toga, A.W., Lopez, O.L., Aizenstein, H.J., & Becker, J.T. (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD41 T lymphocyte decline. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15647-15652. (Pubitemid 41528110)
107. Tozzi,V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori,M.F., Visco-Comandini, U., y Narciso, P. (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: Prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes, 45(2), 174-182. (Pubitemid 46869810)
108. Tozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R., Galgani, S., Corpolongo, A., y Narciso, P. (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11(3), 265-273. (Pubitemid 41122414)
109. Valcour, V.G., Shikuma, C.M., Watters, M.R., & Sacktor, N.C. (2004). Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. AIDS, 18(Suppl. 1), S79-S86. (Pubitemid 38365910)
110. Valcour, V.G., Yee, P., Williams, A.E., Shiramizu, B., Watters, M., Selnes, O.,ySacktor, N. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection-The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12(5), 387-391. (Pubitemid 44650051)
111. van Gorp, W.G., Wilkins, J.N., Hinkin, C.H., Moore, L.H., Hull, J., Horner, M.D., & Plotkin, D. (1999). Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry, 56(1), 85-89. (Pubitemid 29055054)
112. Weber, R., Sabin, C.A., Friis-Moller, N., Reiss, P., El-Sadr, W.M., Kirk, O., y Lundgren, J.D. (2006). Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Archives of Internal Medicine, 166(15), 1632-1641. (Pubitemid 44232373)
113. Wechsler, D. (1997). Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: The Psychological Corporation.
114. Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schuler, A., Ennen, J.C., y Boker, K.W. (2004). Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41(5), 845-851. (Pubitemid 39434316)
115. Wilkinson, J., Radkowski, M., & Laskus, T. (2009). Hepatitis C virus neuroinvasion: Identification of infected cells. Journal of Virology, 83(3), 1312-1319.
116. Woods, S.P., Moore, D.J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152-168.